Cited by 159Extracellular vesicles in diseaseMesenchymal stem cell researchNanoparticle-Based Drug Delivery

Exosomes and stem cells in degenerative disease diagnosis and therapy

Open access
Chang, Yu-Hsun, Wu, Kung-Chi, Harn, Horng-Jyh, Lin, Shinn-Zong, Ding, Dah-Ching·2018·Cell Transplantation

Abstract

Stroke can cause death and disability, resulting in a huge burden on society. Parkinson's disease (PD) is a chronic neurodegenerative disorder characterized by motor dysfunction. Osteoarthritis (OA) is a progressive degenerative joint disease characterized by cartilage destruction and osteophyte formation in the joints. Stem cell therapy may provide a biological treatment alternative to traditional pharmacological therapy. Mesenchymal stem cells (MSCs) are preferred because of their differentiation ability and possible derivation from many adult tissues. In addition, the paracrine effects of MSCs play crucial anti-inflammatory and immunosuppressive roles in immune cells. Extracellular vesicles (EVs) are vital mediators of cell-to-cell communication. Exosomes contain various molecules such as microRNA (miRNA), which mediates biological functions through gene regulation. Therefore, exosomes carrying miRNA or other molecules can enhance the therapeutic effects of MSC transplantation. MSC-derived exosomes have been investigated in various animal models representing stroke, PD, and OA. Exosomes are a subtype of EVs. This review article focuses on the mechanism and therapeutic potential of MSC-derived exosomes in stroke, PD, and OA in basic and clinical aspects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0963689717723636

Cites

205 of 205 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chang, Y.-H., Wu, K.-C., Harn, H.-J., Lin, S.-Z., & Ding, D.-C.
Affiliations
  • Tzu Chi University (TW)
  • Buddhist Tzu Chi General Hospital (TW)
  • Tzu Chi Foundation (TW)
Corresponding author
Ding, Dah-Ching
Venue
Cell Transplantation
Published
2018-03
Volume
27
Issue
3
Pages
349-363
ISSN
  • 0963-6897 (ISSN-L)
  • 1555-3892
OpenAlex
W2801124446
Cited by
159
References
205
Citations by year
2026: 5 · 2025: 16 · 2024: 17 · 2023: 22 · 2022: 32 · 2021: 33 · 2020: 16 · 2019: 14 · 2018: 4
FWCI
1.64
Type
journal article
Language
en
Open access
Locations
  • Cell Transplantation (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
exosomes, mesenchymal stem cells, extracellular vesicles, stroke, Parkinson's disease, osteoarthritis, degenerative diseases, microRNA, stem cell therapy, paracrine effects, cartilage destruction, neurodegeneration, cell-to-cell communication
MeSH terms
Extracellular Vesicles, Animals, Humans, Osteoarthritis, Parkinson Disease, Stem Cells, Stroke, MicroRNAs, Exosomes, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review